rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

CareDx, Inc.

CDNA · Nasdaq

Health CareDiagnostics & LabsLeading

CDNA stood above a rising 150-day average in 43 of the last 52 weekly readings, including each of the last 27 weeks. It is 83.3% above that average now. Diagnostics & Labs: 48% of its 44 stocks in an uptrend (−2 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
27 in a row
Industry in uptrend
48% -2 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$26.4M
Officials’ trades on record
14
Institutions holding
214 (+36)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 43 of 52 weeks.

17 Apr – 16 Oct
20%38%55%Apr 26Jun 26Jul 26Sep 26Oct 26

Diagnostics & Labs: About half its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$10.6M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

14 disclosed lines: House 14, Senate 0, executive 0; 2 people.

WhoDidAmountTraded
Daniel S. Goldman House: U.S. House ClerkNY10sold$1k–$15k6 Mar 2023filed 17 Apr 2023
Tom Malinowski House: U.S. House ClerkNJ07bought$15k–$50k2 Mar 2021filed 10 Apr 2021
Tom Malinowski House: U.S. House ClerkNJ07sold$1k–$15k11 Jan 2021filed 26 Aug 2021
Tom Malinowski House: U.S. House ClerkNJ07sold$1k–$15k8 Jan 2021filed 26 Aug 2021
Tom Malinowski House: U.S. House ClerkNJ07sold$15k–$50k6 Jan 2021filed 26 Aug 2021
Tom Malinowski House: U.S. House ClerkNJ07bought$1k–$15k29 Dec 2020filed 26 Aug 2021
Tom Malinowski House: U.S. House ClerkNJ07bought$1k–$15k23 Dec 2020filed 26 Aug 2021
Tom Malinowski House: U.S. House ClerkNJ07bought$1k–$15k7 Dec 2020filed 26 Aug 2021
Tom Malinowski House: U.S. House ClerkNJ07bought$1k–$15k16 Nov 2020filed 26 Aug 2021
Tom Malinowski House: U.S. House ClerkNJ07sold$1k–$15k9 Oct 2020filed 26 Aug 2021
Tom Malinowski House: U.S. House ClerkNJ07sold$1k–$15k19 Jun 2019filed 5 Mar 2021
Tom Malinowski House: U.S. House ClerkNJ07sold$1k–$15k17 Jun 2019filed 5 Mar 2021

Insiders

Buy orders, 12 months0
Sale orders, 12 months22
Buyers · sellers0 · 7
WhoDidSharesTraded
George BickerstaffDirectorsold20,000at $46.295 Aug 2026filed 6 Aug 2026
Jeffrey Adam NovackSecretary and General Counselsold2,188at $46.155 Aug 2026filed 6 Aug 2026
Jeffrey Adam NovackSecretary and General Counselsold500at $46.755 Aug 2026filed 6 Aug 2026
Christine CournoyerDirectorsold16,000at $46.944 Aug 2026filed 6 Aug 2026
Michael GoldbergDirectorsold44,700at $47.064 Aug 2026filed 6 Aug 2026
John Walter Hanna, Jr.President and CEOsold50,000at $36.1116 Jul 2026filed 17 Jul 2026
John Walter Hanna, Jr.President and CEOsold68,000at $39.0116 Jul 2026filed 17 Jul 2026
Hannah ValantineDirectorsold28,679at $36.1416 Jul 2026filed 17 Jul 2026
Hannah ValantineDirectorsold100at $36.5516 Jul 2026filed 17 Jul 2026
John Walter Hanna, Jr.President and CEOsold39,900at $29.2429 Jun 2026filed 30 Jun 2026
John Walter Hanna, Jr.President and CEOsold100at $29.0026 Jun 2026filed 30 Jun 2026
John Walter Hanna, Jr.President and CEOsold17,683at $24.0315 Jun 2026filed 17 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders214+36 on the quarter
New · exited53 · 17
Reported value$1.5B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20264,814,709$137.2M+292,613+6.5%
STATE STREET CORPreduced · filed 7 Aug 20262,468,858$70.4M-291,527−10.6%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20262,197,475$62.6M+37,018+1.7%
DEERFIELD MANAGEMENT COMPANY, L.P.reduced · filed 14 Aug 20261,997,618$56.9M-193,382−8.8%
ARK Investment Management LLCreduced · filed 14 Aug 20261,953,531$55.7M-274,025−12.3%
Boston Partnersadded · filed 4 Aug 20261,937,601$55.2M+54,067+2.9%
BAMCO INCreduced · filed 14 Aug 20261,937,326$55.2M-1,399,083−41.9%
GAGNON SECURITIES LLCadded · filed 5 Aug 20261,770,735$50.5M+8,861+0.5%
Chevy Chase Trust Holdings, LLCreduced · filed 14 Aug 20261,437,416$41.0M-66,659−4.4%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20261,328,037$37.9M+73,923+5.9%
31 Mar 2023 – 30 Jun 2026
127169211Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Michael Goldberg Company insiderDirector · last 2 Oct 20261 · 13
Jeffrey Adam Novack Company insiderSecretary and General Counsel · last 1 Oct 20260 · 12
Jessica Meng Company insiderChief Commercial Officer · last 1 Oct 20260 · 0
John Walter Hanna Jr. Company insiderPresident and CEO · last 1 Oct 20260 · 10
Keith Kennedy Company insiderCFO & COO · last 1 Oct 20260 · 0
George Bickerstaff Company insiderDirector · last 5 Aug 20260 · 7
Christine Cournoyer Company insiderDirector · last 4 Aug 20260 · 3
Hannah Valantine Company insiderDirector · last 16 Jul 20260 · 3
Fred E. Cohen Company insiderDirector · last 12 Jun 20260 · 0
Richard Bryan Riggsbee Company insiderDirector · last 12 Jun 20260 · 0
Suresh Gunasekaran Company insiderDirector · last 12 Jun 20260 · 0
Arthur A. Torres Company insiderDirector · last 15 May 20261 · 2

Same industry

XGN ExagenLeading+49%
NTRA NateraLeading+46%
PSNL PersonalisLeading+35%
BDSX BiodesixLeading+19%

Distance from each stock’s own 150-day average.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 2025-8.1%
Return on capital employedFY 2025 · to 31 Dec 2025-9.5%
Research spendFY 2025 · to 31 Dec 202518.8%
Share count trendFY 2025 · to 19 Feb 20260.6%
Cash and equivalentsFY 2025 · to 31 Dec 2025$65.4M

Analyst forecasts

No analyst forecasts yet.